Home > Income Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Consolidated Net Profit

    Back to Income Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Consolidated Net Profit ₹25 Cr₹20 Cr₹20 Cr₹1,053,410 Cr₹10 Cr

What is the latest Consolidated Net Profit of SYNCOM FORMULATIONS (INDIA) ?

The latest Consolidated Net Profit ratio of SYNCOM FORMULATIONS (INDIA) is ₹25 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹25 Cr
Mar2024₹20 Cr
Mar2023₹20 Cr
Mar2022₹1,053,410 Cr
Mar2017₹10 Cr

How is Consolidated Net Profit of SYNCOM FORMULATIONS (INDIA) Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹25 Cr
26.12
Mar2024 ₹20 Cr
1.42
Mar2023 ₹20 Cr
-100.00
Mar2022 ₹1,053,410 Cr
10,171,878.56
Mar2017 ₹10 Cr -

Compare Consolidated Net Profit of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,333.9 Cr 3.2% -1.1% -17.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,591.0 Cr 3.2% 12.4% 11.5% Stock Analytics
DIVIS LABORATORIES ₹183,512.0 Cr 1.8% 11% 10.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,850.0 Cr 3.8% 6.7% 35.5% Stock Analytics
CIPLA ₹113,884.0 Cr 6.2% 13.9% -4.6% Stock Analytics
DR REDDYS LABORATORIES ₹111,339.0 Cr 5.4% 8% 9.1% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

3.2%

-1.1%

-17.4%

SENSEX

0.9%

-3.6%

-7.3%


You may also like the below Video Courses